ArticleArthroplasty today2026
"E-Spot" (Obturator 'E'xternus Tendon Femoral Origin) as an Intraoperative Landmark for Femoral Preparation During "Off-Table" Anterior Approach.
Article in Arthroplasty today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study introduces the obturator externus tendon femoral origin, termed "E-spot," as a landmark during "off-table" anterior approach total hip arthroplasty (THA). Aims were to determine whether the E-spot could (1) be identified reliably in all cases and (2) help as a reference during femoral preparation to determine the extent of capsular release and femoral implant position. Methods: A retrospective analysis of 306 consecutive patients who underwent primary THA by the senior author via an anterior approach between October 2022 and October 2024 was conducted. We attempted to visualize and preserve the obturator externus tendon in all cases and then use it as a reference to determine the extent/completion of capsular release and femoral implant position. Clinical outcomes and complications were assessed at a minimum of 6 months postoperatively to up to 2 years. Results: E-spot could (1) be reliably identified as well as (2) the stem to E-spot distance measured in every case (306 out of 306 or 100% reproducibility). There was 1 periprosthetic fracture (Vancouver B2) requiring revision surgery at 2 months postoperatively and 1 dislocation at 3 months postoperatively (0.65% overall early complication rate). No other surgical complications were observed. Conclusions: Identifying E-spot in a systematic way is a safe and reliable method of enabling femoral exposure and referencing femoral component position. Based on these results, we now routinely use E-spot to determine the completion of femoral capsular release, assess femoral component position, assure hip stability, and protect the trochanter from injury during off-table anterior THA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.